Paper23010705
Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
Sutton LM and 6 others. Am J Clin Pathol, 2012. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma. Papers, record 23010705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23010705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Breast Neoplasms | Major topic |
| Erb-b2 Receptor Tyrosine Kinases | Major topic |
| Receptors, Androgen | Major topic |
| Receptors, Estrogen | Major topic |
| Receptors, Progesterone | Major topic |
| Biomarkers, Tumor | |
| Female | |
| Humans | |
| Ki-67 Antigen | |
| Neoplasm Metastasis | |
| Prognosis |
Source PubMed
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42094881 | Glucose metabolic reprogramming: a novel strategy to enhance radiotherapy response to triple-negative breast cancer. | Front Public Health | 2026 | https://conductscience.org/library/papers/42094881 | PubMed |
| 41948492 | Assessing the prognostic role of androgen receptor expression in non-metastatic triple-negative breast cancer. | Front Oncol | 2026 | https://conductscience.org/library/papers/41948492 | PubMed |
| 41079087 | Case Report: Androgen receptor-positive, locoregionally advanced breast cancer in a transgender man and an update on breast cancer management in a gender-diverse patient population. | Front Oncol | 2025 | https://conductscience.org/library/papers/41079087 | PubMed |
| 40862714 | Identification of Epigenetic Regulatory Networks of Gene Methylation-miRNA-Transcription Factor Feed-Forward Loops in Basal-like Breast Cancer. | Cells | 2025 | https://conductscience.org/library/papers/40862714 | PubMed |
| 40685652 | Androgen receptor expression in triple negative breast cancer: an Algerian population study. | Libyan J Med | 2025 | https://conductscience.org/library/papers/40685652 | PubMed |
| 40448099 | C/EBPβ increases tumor aggressiveness by enhancing KIFC1 expression in androgen receptor negative triple negative breast cancer. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40448099 | PubMed |
| 39851328 | Dual Functions of Androgen Receptor Overexpression in Triple-Negative Breast Cancer: A Complex Prognostic Marker. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/39851328 | PubMed |
| 39588561 | Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis. | Mol Cancer Ther | 2025 | https://conductscience.org/library/papers/39588561 | PubMed |
| 39555351 | Analyzing Androgen Receptor Expression in Breast Cancer: Insights into Histopathological Parameters and Hormone Receptor Status Among Indian Women. | Indian J Surg Oncol | 2024 | https://conductscience.org/library/papers/39555351 | PubMed |
| 39421321 | Expression of nuclear receptors and glucose metabolic pathway proteins in sebaceous carcinoma: Androgen receptor and monocarboxylate transporter 1 have a key role in disease progression. | Oncol Lett | 2024 | https://conductscience.org/library/papers/39421321 | PubMed |
| 39399414 | Triple-Negative Breast Cancer: Tumor Immunogenicity and Beyond. | Int J Breast Cancer | 2024 | https://conductscience.org/library/papers/39399414 | PubMed |
| 39020535 | Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile. | Rom J Morphol Embryol | 2024 | https://conductscience.org/library/papers/39020535 | PubMed |
| 38741650 | Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC). | Indian J Surg Oncol | 2024 | https://conductscience.org/library/papers/38741650 | PubMed |
| 38374890 | Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer. | J Bone Oncol | 2024 | https://conductscience.org/library/papers/38374890 | PubMed |
| 38130277 | Androgen Receptor Expression in ER and PR Negative Breast Cancer-A Study from a Tertiary Hospital in Northern India. | South Asian J Cancer | 2023 | https://conductscience.org/library/papers/38130277 | PubMed |
| 38058819 | Advancing breast cancer subtyping: optimizing immunohistochemical staining classification with insights from real-world Taiwanese data. | Am J Cancer Res | 2023 | https://conductscience.org/library/papers/38058819 | PubMed |
| 38003261 | Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003261 | PubMed |
| 37817975 | Prevalence of Androgen Receptor in Invasive Breast Cancer and Its Association with Clinicopathologic Features in East Azarbaijan Province of Iran: A Cross-Sectional Study. | Int J Hematol Oncol Stem Cell Res | 2023 | https://conductscience.org/library/papers/37817975 | PubMed |
| 37438515 | Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study. | Breast Cancer Res Treat | 2023 | https://conductscience.org/library/papers/37438515 | PubMed |
| 37435469 | SAKK 21/12: a phase II trial of transdermal CR1447 in breast cancer patients. | Endocr Oncol | 2022 | https://conductscience.org/library/papers/37435469 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23010705
GET https://conductscience.org/api/papers/v1/23010705/cited_by?page=2